HTB | HIV i-Base

HTB

Weight gain and loss at BHIVA, + COVID-19 - and vaccine responses at low CD4...

Featured HTB: no. 6 – plus HIV and COVID-19 (1 June 2021) 1 June 2021. Related: Editorial.
Featured HTB: no. 5 – plus HIV and COVID-19 (3 May 2021) 3 May 2021. Related: Editorial, Special reports.
Featured HTB: no. 4 – plus HIV and COVID-19 (1 April 2021) 1 April 2021. Related: Editorial.
Featured CROI 2021: First results using capsid inhibitor lenacapavir against MDR HIV: potential for six-monthly ART and PrEP 1 April 2021. Related: Conference reports, Antiretrovirals, CROI 2021 (virtual).
Featured HTB: no. 3 – plus HIV and COVID-19 (12 March 2021) 12 March 2021. Related: Editorial, Special reports.
Featured HTB: no. 2 – plus HIV and COVID-19 (24 February 2021) 24 February 2021. Related: Editorial.
Featured HTB: no. 1 – plus HIV and COVID-19 (22 January 2021) 22 January 2021. Related: Editorial.
Featured HTB: no. 13/14 – HIV and COVID-19: issue 10 (9 December 2020) 9 December 2020. Related: Editorial.
Featured HTB: no. 12 – HIV and COVID-19: issue 9 (11 November 2020) 11 November 2020. Related: Editorial.
Featured In Memory: Timothy Ray Brown – the Berlin patient, the first person to be cured of HIV 14 October 2020. Related: In memory.
Predicting likelihood of post treatment control in HIV cure-related studies that interrupt ART 15 June 2021. Related: Early access, Cure research.
Failure of mRNA vaccines to produce antibody responses in late diagnosed HIV with low CD4 count and high viral load 3 June 2021. Related: Early access, COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
i-Base appeal: please support i-Base with £5 or £10 a month 1 June 2021. Related: Editorial.
5th joint BHIVA/BASSH conference 2021 1 June 2021. Related: Conference reports, BHIVA/BASSH 2021.
Weight changes on ART and how to lose weight successfully 1 June 2021. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications, Nutrition.
Selected presentations at BHIVA: COVID-19, PrEP in the UK, community involvement and more… 1 June 2021. Related: Conference reports, COVID-19: transmission & prevention, COVID-19.
28th Conference on Retroviruses and Opportunistic Infections (CROI 2021) virtual 1 June 2021. Related: Conference reports, CROI 2021 (virtual).
No differences in outcomes among women with and without HIV with high-risk pregnancies and COVID-19 1 June 2021. Related: Conference reports, Pregnancy, COVID-19: pathogenesis, COVID-19.
Dolutegravir-based regimens safe and effective in pregnancy and postpartum 1 June 2021. Related: Conference reports, Pregnancy, CROI 2021 (virtual).
Dolutegravir superior to standard of care in children and adolescents: results from the ODYSSEY trial 1 June 2021. Related: Conference reports, Paediatric care, CROI 2021 (virtual).
High efficacy of HPV vaccine in HIV positive gay men 1 June 2021. Related: Coinfections and complications, Cancer and HIV.
HPV vaccine does not prevent short-term recurrence of high grade lesions in HIV positive gay men 1 June 2021. Related: Coinfections and complications, Cancer and HIV.
HIV bNAbs prevent intravenous exposure to SHIV in macaques as PrEP 1 June 2021. Related: HIV prevention and transmission.
HIV associated with higher risk of severe COVID-19 in US cohort 1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
MHRA authorises Janssen/J&J COVID-19 vaccination in the UK 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Reduced antibody responses to first dose of mRNA COVID-19 vaccines in HIV positive people with a lower CD4 count 1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
France routinely recommends third dose of COVID-19 vaccine for some people with reduced immune function 1 June 2021. Related: COVID-19: vaccine research, COVID-19: guidelines, COVID-19.
US CDC reports 10,000 breakthrough infections after full vaccination: showing success of vaccine programme 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Cases of COVID-19 reported including deaths in care home residents after full-course vaccination 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Israeli study reports reduced vaccine efficacy in people with immune suppression until 14 days after the second dose 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Novavax reports 43% efficacy against B.1.351 South African variant but negative impact in HIV positive participants 1 June 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Oxford/AZ vaccine linked to 242 rare bloods clots in the UK: alternative recommended for people younger than 40 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccine candidate from GSK and Sanofi to move to phase 3 placebo controlled study 1 June 2021. Related: COVID-19: vaccine research, COVID-19.
Meta-analysis of 18 ivermectin studies reports benefit 1 June 2021. Related: COVID-19: treatment access, COVID-19.
Asymptomatic infection has similar SARS-CoV-2 viral load to mild COVID-19 1 June 2021. Related: COVID-19: transmission & prevention, COVID-19.
Missed TB diagnoses during COVID-19 outbreaks despite prolonged respiratory symptoms 1 June 2021. Related: COVID-19: complications, COVID-19.
Correlation between COVID-19 severity and immune responses after six months 1 June 2021. Related: COVID-19: pathogenesis, COVID-19: transmission & prevention, COVID-19.
Durable antibody responses 9 months after exposure irrespective of symptoms: broader vaccine coverage still needed to reach herd immunity 1 June 2021. Related: COVID-19: pathogenesis, COVID-19: transmission & prevention, COVID-19.
Future meetings and webinars 2021 1 June 2021. Related: Future meetings.
HTB: no. 6 – plus HIV and COVID-19 (1 June 2021) 1 June 2021. Related: PDFs.
In memory: Paul Decle – community activist, gardener and friend 3 May 2021. Related: In memory.
Joint BHIVA/BASSH Spring Conference 2021 3 May 2021. Related: Conference reports, BHIVA/BASHH 5th Virtual 2021.
BHIVA registry reports HIV is independently linked to worse presentation and outcomes from COVID-19 3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19, BHIVA/BASHH 5th Virtual 2021.
HIV is linked to higher mortality from COVID-19 compared to HIV negative: 60% of deaths were black ethnicity 3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19, BHIVA/BASHH 5th Virtual 2021.
Case-control study of HIV positive people hospitalised with COVID-19 3 May 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19, BHIVA/BASHH 5th Virtual 2021.
UK government to cut international HIV support to UNAIDS by 80% 3 May 2021. Related: Treatment access.
NICE guidelines on management of chronic pain: exercise but not opiods 3 May 2021. Related: Guidelines, Side effects, Coinfections and complications.
US CDC includes HIV as medical criteria for priority to COVID-19 vaccines 3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: guidelines, COVID-19.
Review of research into SARS-CoV-2 and HIV coinfection 3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Similar immune responses to the Oxford/AZ COVID vaccine reported In HIV positive and HIV negative participants 3 May 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Low responses to mRNA COVID-19 vaccines in those older than 80 vs <60 years and in recipients of solid organ transplants 3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Two cases of viral breakthrough infections despite full protection from Pfizer mRNA vaccination 3 May 2021. Related: COVID-19: vaccine research, COVID-19.
US post-authorisation safety data on Pfizer and Moderna vaccines 3 May 2021. Related: COVID-19: vaccine research, COVID-19.
EMA review of Oxford/AZ vaccine and rare blood clots reported in the EU 3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Interim results report 80% efficacy for India’s COVAXIN vaccine 3 May 2021. Related: COVID-19: vaccine research, COVID-19.
Three new COVID-19 vaccine studies enrolling in the UK 3 May 2021. Related: COVID-19: vaccine research, COVID-19: research studies, COVID-19.
Dexamethasone: final results from RECOVERY study 3 May 2021. Related: COVID-19: investigational drugs, COVID-19.
No impact from anakinra in mild/moderate COVID-19 pneumonia 3 May 2021. Related: COVID-19: investigational drugs, COVID-19.